Skip Nav Destination
Close Modal
Search Results for
qaly
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Book Series
Date
Availability
1-20 of 57 Search Results for
qaly
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Book Chapter
Series: Contributions to Nephrology
Volume: 185
Published: 26 May 2015
10.1159/000380976
EISBN: 978-3-318-05465-1
...-adjusted life years (QALY) and the incremental cost-effectiveness ratio (ICER). QALY were estimated using the EuroQOL-5 dimension. Reimbursement for medical fees in the national health insurance system was used as an indicator of costs. In a comparative analysis of hemodialysis and online HDF, a total...
Book Chapter
Series: Nestlé Nutrition Institute Workshop Series
Volume: 82
Published: 02 November 2015
10.1159/000382009
EISBN: 978-3-318-05499-6
... benefits to the patient. The most used measure of this health benefit is the quality-adjusted life year (QALY). The lower the ratio of cost per QALY gained, the more cost-effective a health intervention is said to be. Threshold values are often used in coverage decisions. Medicinal products with ratios...
Book Chapter
Series: Developments in Ophthalmology
Volume: 55
Published: 27 October 2015
10.1159/000431205
EISBN: 978-3-318-05565-8
... ]. Others reserve cost-utility analysis for those studies which measure the improvement in length of life and/or quality of life for the resources expended using dollars expended per quality-adjusted life year (QALY). The present authors agree that the term cost-utility analysis should be used to describe...
Book Chapter
Series: Advances in Oto-Rhino-Laryngology
Volume: 69
Published: 07 July 2010
10.1159/000318517
EISBN: 978-3-8055-9471-4
... disability. The main outcome of most generic HR-QoL questionnaires is one single measure called utility. It ranges between 1 (perfectly happy) and 0 (death). The change in utility owing to a specific intervention is called the utility gain and it is used to determine the quality-adjusted life-years or QALYs...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459694
EISBN: 978-3-318-06042-3
... can be limited by cost. Aflibercept and ranibizumab are substantially more expensive than bevacizumab. A post-hoc analysis was conducted to calculate the clinical costs, benefits, and cost effectiveness of each drug. The overall medical costs and quality-adjusted life-years (QALY) were calculated...
Book Chapter
Book: Nutrition and Growth
Series: World Review of Nutrition and Dietetics
Volume: 106
Published: 12 February 2013
10.1159/000342527
EISBN: 978-3-318-02266-7
... perspective is a complex matter, ranging from the early stages of intrauterine development up to adult ages and ageing processes. Cost/benefit analyses of interventions on growth such as cost per DALYs (disability-adjusted life years) or QALYs (quality-adjusted life years) should be expanded on population...
Book Chapter
Series: Contributions to Nephrology
Volume: 185
Published: 26 May 2015
EISBN: 978-3-318-05465-1
... Journal 1991;101:1277-1286. 6. Takura T, Sawa Y: Medical economics of transplant: economic concepts for future development of organ transplantation. Transplantation 2009;44:60-68. 7. Kontodimopoulos N, Niakas D: An estimate of lifelong costs and QALYs in renal replacement therapy based on patients...
Book Chapter
Series: Advances in Oto-Rhino-Laryngology
Volume: 81
Published: 07 May 2018
10.1159/000485529
EISBN: 978-3-318-06315-8
... with a CHA for a range of reasons. There are some limited studies investigating the cost effectiveness of the VSB. These have demonstrated a range of cost per QALY of AMEI implantation. Snik et al. [ 24 ] reported a cost of EUR 18,655 per QALY for the use of the VSB in SNHL in patients with severe otitis...
Book Chapter
Book: Glaucoma
Series: ESASO Course Series
Volume: 8
Published: 30 September 2016
10.1159/000446148
EISBN: 978-3-318-05891-8
... together using the quality-adjusted life year (QALY). This is calculated by multiplying the utility value gain obtained by an intervention by the years of benefit gained. For example, if a surgical intervention such as cataract extraction results in an improved utility value from 0.5 pre-operatively to 0.8...
Book Chapter
Series: Frontiers in Diabetes
Volume: 24
Published: 17 November 2014
10.1159/000363486
EISBN: 978-3-318-02337-4
... policies or interventions in type 1 and type 2 diabetes mellitus. Three studies were performed in the UK and showed a gain in quality-adjusted life-years (QALYs) for people receiving CSII compared with MDI therapy at an increased cost. The incremental cost-effectiveness ratios for CSII compared...
Book Chapter
Series: Pediatric and Adolescent Medicine
Volume: 19
Published: 27 January 2015
10.1159/000368126
EISBN: 978-3-318-02799-0
... to comorbidity and eventually into quality-adjusted life years (QALYs). In long-term evaluations, discounting is applied in order to account for the time preference of the decision makers. Thresholds for the society's willingness to pay for a certain intervention effect have been defined in some countries...
Book Chapter
Book: Leksell Radiosurgery
Series: Progress in Neurological Surgery
Volume: 34
Published: 28 May 2019
10.1159/000493072
EISBN: 978-3-318-06422-3
... cavernous malformation showing adverse radiation effects. Projected Cost-Benefit Analysis of Leksell Stereotactic Radiosurgery Table 2 shows a projected cost-benefit comparison. If SRS is compared to no treatment for CM the efficiency (quality-adjusted life years; QALY) increases from 25.25...
Book Chapter
Series: Nestlé Nutrition Institute Workshop Series
Volume: 66
Published: 22 July 2010
EISBN: 978-3-8055-9455-4
..., 2006;121-158 30. Dolan P, Shaw R, Tsuchiya A, et al: QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005;14:197-208 ...
Book Chapter
Series: Pediatric and Adolescent Medicine
Volume: 19
Published: 27 January 2015
EISBN: 978-3-318-02799-0
... 1995;273:1093-1098. 29. Ungar WJ: Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? Pharmacoeconomics 2011;29:641-652. 30. Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A: Methods for assessing...
Book Chapter
Series: Nestlé Nutrition Institute Workshop Series
Volume: 66
Published: 22 July 2010
10.1159/000318952
EISBN: 978-3-8055-9455-4
...-effectiveness studies of preventive obesity interventions in children and adolescents PA Physical activity N nutrition SBP school-based program SBEP school-based education program PE physical education DALY disability-adjusted life year QALY quality-adjusted life...
Book Chapter
Series: Advances in Oto-Rhino-Laryngology
Volume: 81
Published: 07 May 2018
EISBN: 978-3-318-06315-8
... patients with severe external otitis. Arch Otolaryngol Head Neck Surg 2006;132:1210-1215. 25. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K: International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010;19:422...
Book
Series: Contributions to Nephrology
Volume: 185
Published online: 21 May 2015
Published in print: 26 May 2015
10.1159/isbn.978-3-318-05465-1
EISBN: 978-3-318-05465-1
Book Chapter
Series: Progress in Neurological Surgery
Volume: 33
Published: 22 January 2018
10.1159/000481105
EISBN: 978-3-318-06202-1
... cost of 22,700 EUR per quality-adjusted life year (QALY = 1 year of life × 1 utility value) for STN DBS. They concluded that this additional cost was cost effective for the benefit in QALY, given that it was below a derived cutoff of 50,000 EUR per QALY, which was in line with similar conclusions...
Book
Series: Nestlé Nutrition Institute Workshop Series: Clinical & Performance Program
Volume: 12
Published: 07 August 2009
10.1159/isbn.978-3-8055-8978-9
EISBN: 978-3-8055-8978-9
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459699
EISBN: 978-3-318-06042-3
... in the cost burden with the 2 treatments for PDR; PRP is less expensive than ranibizumab injections. The cost of PRP as the initial treatment for PDR is lower by almost 60% than intravitreal ranibizumab 0.5 mg used over the first 2 years. Lin et al. [ 21 ] reported the quality-adjusted life year (QALY) value...
1